By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Life expectancy

Coffee consumption and healthy ageing to be discussed at Global Coffee Forum: Expo Milano 2015

Coffee consumption and healthy ageing to be discussed at Global Coffee Forum: Expo Milano 2015

September 10, 2015

ISIC hosts panel discussion on cognitive decline, diabetes and cardiovascular disease

The Institute for Scientific Information on Coffee (ISIC), a not-for-profit organisation devoted to the study and disclosure of science related to coffee and health, is delighted to be hosting a panel discussion on coffee and ageing at the Global Coffee Forum taking place on 30 September 2015 during the Expo Milano 2015 in Italy.

A number of scientific research studies have shown that there is a favourable relationship between coffee consumption and healthy ageing. Recent research revealed that drinking three to five cups of coffee per day could help reduce an individual’s cardiovascular disease mortality risk by up to 21 per cent1. Another study showed that consuming three to four cups of coffee per day is associated with an approximate 25 per cent lower risk of developing type 2 diabetes compared to consuming none or less than two cups per day2. Further scientific evidence has consistently linked regular, moderate coffee consumption with a possible reduced risk of developing Alzheimer’s Disease3,4.

The ISIC ‘Coffee and Healthy Ageing’ panel discussion brings together leading scientists from across Europe to discuss the latest scientific research and insights on coffee consumption and cognitive decline, diabetes and cardiovascular disease.

The panel discussion will be moderated by Alok Jha, a journalist, author and broadcaster and science correspondent at ITV News. Three scientific speakers will discuss their fields of expertise and examine the role coffee can play in ageing, including a focus on the neuroprotective effects of caffeine, type 2 diabetes risk reduction and CVD and stroke risk.

Speakers participating are:
• Dr Karen Ritchie, French National Institute for Health and Medical Research, France
• Professor Edith Feskens, Nutrition and Epidemiology at Wagenengen University, The Netherlands
• Dr Carlo La Vecchia, department of clinical Sciences and Community, University of Milan, Italy

ISIC’s ‘Coffee and Healthy Ageing’ panel discussion will be held on the 30th September 2015 from 16.35-18.00. The panel discussion takes place during the Global Coffee Forum’s Coffee Week.

For more information on coffee and health visit our website www.coffeeandhealth.org

-ends-

References


1. Crippa A. et al. (2014) Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol. 180(8):763-75
2. Huxley R. et al. (2009) Coffee, Decaffeinated Coffee, and Tea Consumption in Relation to Incident Type 2 Diabetes Mellitus. Archives of Internal Medicine. 169:2053-2063
3. Barranco Quintana J.L. et al. (2007) Alzheimer’s disease and coffee: a quantitative review. Neurol Res, 29:91-
4. Santos C. et al. (2010) Caffeine intake and dementia: systematic review and meta-analysis. J Alzheimers Dis, 20(1):187-204.

More latest news

All news articles